Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Titan Pharmaceuticals and FDA discuss path forward for Probuphine

March 4, 2014

Humanetics and USAMRICD enter into CRADA to study BIO-300 to treat phosgene exposure

Feb. 26, 2014

FDA clears path for smoking cessation trial of INV-102

Jan. 30, 2014

Phase I study of novel treatment candidate for alcoholism begins patient recruitment

Jan. 27, 2014

FDA grants orphan drug status to Aeolus' drug candidate for treatment of acute radiation syndrome

Jan. 24, 2014

Neumedicines' HemaMax shown to improve survival outcomes following lethal irradiation

Jan. 10, 2014

Neumedicines joins the Alliance for Biosecurity

Jan. 7, 2014

Takeda submits NDA for fomepizole in Japan

Dec. 30, 2013

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Characterization of novel cocaine metabolizing enzymes for treatment of addiction

Dec. 10, 2013

Popular Stories

University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Beijing Innocare Pharma Tech discloses new GSPT1 degradation inducers
BioWorld Science
Beijing Innocare Pharma Tech Co. Ltd. has synthesized new antibody-drug conjugates comprising antibody or antigen-binding fragment covalently linked to eukaryotic...